GlassScriptPhysician profile
Carletta M Collins
NPI 1740337617
$1,361.09
in general payments reported to CMS, 2019-2025
19 companies · $26.22 in 2025
The $26.22 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,203 · 2020: $30.88 · 2021: $55.98 · 2022: $44.94 · 2025: $26.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $539.00 | 2019 | |
| Pfizer INC. | $169.57 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $136.51 | 2019-2022 | |
| Eisai INC. | $98.75 | 2019 | |
| Amgen INC. | $65.27 | 2019 | |
| Daiichi Sankyo INC. | $64.16 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $43.88 | 2019 | |
| Abbvie INC. | $42.29 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $30.12 | 2019 | |
| Seagen INC. | $28.70 | 2019 | |
| Tesaro, INC. | $26.45 | 2019 | |
| Array Biopharma INC | $22.07 | 2019 | |
| Genentech USA, INC. | $19.63 | 2019 | |
| Lilly USA, LLC | $13.09 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.89 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $12.72 | 2019 | |
| Emd Serono, INC. | $12.33 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carletta Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.